Showing 2101-2110 of 3132 results for "".
- Calling all Applicants: Estée Lauder Companies New Incubation Ventures Launches 2023 BEAUTY&YOU India Programhttps://modernaesthetics.com/news/calling-all-applicants-estee-lauder-companies-new-incubation-ventures-launches-2023-beautyyou-india-program/2473469/The Estée Lauder Companies (ELC) is launching the second edition of BEAUTY&YOU. Created by ELC’s New Incubation Ventures and launched in partnership with India’s preferred beauty and lifestyle retailer, NYKAA, BEAUTY&YOU aims to continue its mission to di
- New Skin-Responsive FUE Technique Improves Hair Restoration Results Among Individuals of African Descent,https://modernaesthetics.com/news/new-skin-responsive-fue-technique-improves-hair-restoration-results-among-individuals-of-african-descent/2473468/A new follicular unit excision (FUE) device may improve hair restoration results among individuals of African descent, according to a study in Dermatologic
- L'Oréal Paris Gives Back: Brand Inducts 10 Changemakers into Its Women of Worth Programhttps://modernaesthetics.com/news/loreal-paris-gives-back-brand-inducts-10-changemakers-into-its-women-of-worth-program/2473466/L'Oréal Paris USA announced its 2023 L'Oréal Paris Women of Wor
- Allergan Aesthetics Announces First JUVÉDERM Dayhttps://modernaesthetics.com/news/allergan-aesthetics-announces-first-ever-juvederm-day/2473461/August 16, 2023 marks the first ever JUVÉDERM® Day. JUVÉDERM Day provides both con
- Two in Three Cosmetic Surgery Injections in the UK Not Administered by Doctorshttps://modernaesthetics.com/news/two-in-three-cosmetic-surgery-injections-in-the-uk-nor-administered-by-doctors/2473453/Two in three neuromodulators or fillers in the UK are not administered by doctors, new research shows. For the study, researchers from UCL in London evaluated 3,000 websites to identify 1,224 independent clinics and 3,667 practitioners who performed cosmetic injections. Of the
- Venus Concept Introduces Medical Advisory Board for AI.MEhttps://modernaesthetics.com/news/venus-concept-introduces-medical-advisory-board-for-aime/2473449/The primary mission of the medical advisory board will be to provide strategic input, guidance, and clinical recommendations regarding the Company's emerging robotic technology, AI.ME, which received its first 510(k) clearance from the U.S. Food and Drug Administration (FDA) in December 2022,
- Acclaro Medical Rolls Our Rebranded UltraClear Cold Fiber Laserhttps://modernaesthetics.com/news/acclaro-medical-rolls-our-rebranded-ultraclear-cold-fiber-laser/2473448/Meet the newly re-branded UltraClear Cold Fiber Laser from Acclaro Medical. From a design perspective, rebranding encompasses an updated logo and color palette and aims to increase recognition of UltraClear's 3DIntelliPulse technology and its ability to provide optima
- What is Exosome Therapy? All Your Questions Answeredhttps://modernaesthetics.com/news/what-is-exosome-therapy-all-your-questions-answered/2473445/Exosomes are among today’s buzziest skincare ingredients, but what exactly are exosomes, how can you choose the best product to recommend to patients, and how can exosomes be used to complement in-office skin rejuvenation procedures? New York City dermatologist Marina I. Pere
- Merz Aesthetics Named Sole Distributor of AccuVein’s Visualization Systemhttps://modernaesthetics.com/news/merz-aesthetics-named-sole-distributor-of-accuveins-visualization-system/2473439/Merz Aesthetics is now the sole authorized distributor of AccuVein’s vein visualization system in the U.S. aesthetics market. A limited initial AccuVein field pilot yielded positive results and significant expansion of both new customers and Merz Aesthetics portfolio ad
- CollPlant Achieves Milestone in Dermal Filler Developmenthttps://modernaesthetics.com/news/collplant-achieves-milestone-in-dermal-filler-development/2473431/CollPlant Biotechnologies hit a milestone in the development of a regenerative dermal filler, and this achievement triggers a $10 million payment from AbbVie to CollPlant. In 2021, CollPlant and AbbVie entered into an exclusive worldwide development and commercializatio